Kelli Stokes is suing Pfizer Inc., McKesson Corporation, Wyeth Pharmaceuticals, and Schwartz Pharma for California products liability. Stokes claims that taking the drug Reglan caused her to develop tar dive dyskinesia, which is a serious neurological movement disorder causes a person's body parts to move involuntarily and uncontrollably.
Reglan is a medication that is prescribed to people suffering from gatroesophageal reflux disease. It is supposed to alleviate heartburn while accelerating the healing of sores and ulcers in the esophagus.
According to Stokes's California drug injury claim, she took Reglan between December 2006 and March 2010 on a generally continuous and/or intermittent basis to relieve her heartburn, abdominal pain, nausea, and chronic bloating. She claims that taking the drug overexposed her to metoclopramide, which caused her to develop this now permanent restless leg syndrome.
Over the past four decades, there have been numerous studies connecting neuroleptic medications to involuntary movement conditions. Yet, per the California dangerous drug complaint, although Wyeth knew that adults shouldn't take Reglan for more than 12 weeks and taking this medication for longer significantly upped their risk of developing a neurological movement disorder, the manufacturer continued to misrepresent that the medication was safe for adults to take for esophageal reflux and nausea beyond this time frame.
Stokes is accusing Wyeth of purposely fooling consumers and the medical community so that the latter would prescribe the drug to patients. Alleging California products liability, she maintains that if Wyeth had marketed drug in a manner that properly disclosed the risks, she would have chosen not to take Reglan. She is also claiming fraud, negligent misrepresentation, deceit by concealment, violation of professional and local business codes, and breach of express and implied warrants.
"There is no cure for tardive dyskinesia and it is undoubtedly a debilitating, life changing side effects," said Irvine Reglan attorney Vincent Howard.
It wasn't until early 2009 that US Food and Drug Administration mandated that Reglan come with a 'black box warning' letting consumers know that it may cause tardive dyskinesia. Symptoms of tar dive dyskinesia may include:
• Facial ticks
• Repetitive, involuntary movements
• Lip pursing, smacking, and puckering
• Blinking or rapid eye movements
• Tongue protrusion
• Restless leg syndrome
• Finger and hand twitching
• Swaying of the truck and hip
No drug should leave you permanently disabled. "There are steps that an experienced dangerous drug law firm can take to find out if you can hold a manufacturer liable through an Orange County, California Reglan lawsuit. You also don't want to go after a large corporation without legal, said Anaheim drug injury lawyer Vincent Howard.
FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing Drugs, FDA, February 26, 2009
More Blog Posts:
Yasmin Lawsuits: Products Liability Settlements Have Cost Bayer $142M in the US So Far, California Injury Lawyers, May 28, 2012
Fosamax Update: FDA Still Questioning Benefits of Long-Term Use, Recommends Some Women Stop After Five Years, California Injury Lawyers, May 19, 2012
$65M Botox Lawsuit: Irvine-Based Allergan Reaches Confidential Products Liability Settlement with Plaintiff, California Injury Lawyers, May 23, 2012
Other Serious Reglan Side Effects:
• Parkinson's-type symptoms